Education
Supports ENT trainees, pathology residents, medical students, surgeons, clinicians, and cytotechnologists learning how head and neck tumors present in African settings.
A clinical-image-first African registry of head and neck tumor presentations, linking actual clinical images with radiology, cytology, histology, and future precision oncology data where available.
The registry starts with what is available today: visible clinical presentation images of head and neck masses and lesions. It is designed to preserve valuable African clinical data while building toward education, research, digital pathology, and AI-ready cancer datasets.
Many global image datasets focus on histology or radiology alone. This registry begins with the visible clinical presentation: the neck mass, oral lesion, facial swelling, salivary gland mass, thyroid swelling, skin lesion, or other head and neck tumor presentation.
Supports ENT trainees, pathology residents, medical students, surgeons, clinicians, and cytotechnologists learning how head and neck tumors present in African settings.
Creates structured clinical-image data for future studies on presentation, diagnostic pathways, clinicopathologic correlation, referral delay, and outcomes.
Builds responsibly governed African image datasets for future validation of decision-support, digital pathology, and precision oncology tools.
Cytology-only, histology-only, and cytology-plus-histology-only cases belong in the broader African Pathology Image Registry. This focused registry is anchored by the clinical presentation image.
Cases with a clinical presentation image, with optional radiology, cytology, histology, gross specimen images, and best available diagnosis.
Cases without clinical presentation images are redirected to the broader African Pathology Image Registry.
The registry is designed so valuable retrospective clinical images are not lost simply because age, sex, radiology, cytology, or histology is missing. Each case is clearly labelled by evidence level.
The first phase starts pragmatically with clinical presentation images and available linked diagnostic material. Over time, where ethical approval, patient consent, funding, FFPE block access, and institutional partnerships allow, Kebeza aims to expand the registry into a richer African oncology intelligence platform.
Future layers may include FFPE block-derived sequencing, tumor molecular profiles, histology-genomics correlation, treatment received, treatment response, recurrence, follow-up, outcomes, survival, referral pathway data, and AI-ready structured datasets.
Public teaching cases should be de-identified and approved before publication. Restricted datasets should remain under controlled access, with review for visible identifiers, embedded radiology labels, hospital numbers, names, dates of birth, facial identification, duplicate cases, and uncertain diagnosis labels.
Images and metadata are reviewed before inclusion in public-facing teaching or research views.
Cases can be separated into public teaching, restricted research, and private partner datasets.
The registry is positioned as African-owned cancer data infrastructure built from real diagnostic pathways.
Kebeza is seeking collaborators in ENT surgery, pathology, radiology, oncology, medical education, AI, data governance, and African cancer research implementation.